Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,037,384
  • Shares Outstanding, K 117,708
  • Annual Sales, $ 23,870 K
  • Annual Income, $ -290,060 K
  • 60-Month Beta 1.51
  • Price/Sales 165.85
  • Price/Cash Flow N/A
  • Price/Book 9.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.42
  • Number of Estimates 5
  • High Estimate -0.39
  • Low Estimate -0.47
  • Prior Year -1.16
  • Growth Rate Est. (year over year) +63.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.64 +15.72%
on 06/12/20
39.88 -13.99%
on 06/23/20
+1.59 (+4.86%)
since 06/10/20
3-Month
26.34 +30.22%
on 04/15/20
39.88 -13.99%
on 06/23/20
+4.55 (+15.29%)
since 04/09/20
52-Week
9.51 +260.67%
on 07/22/19
39.88 -13.99%
on 06/23/20
+22.80 (+198.26%)
since 07/10/19

Most Recent Stories

More News
Top Ranked Momentum Stocks to Buy for July 6th

Top Ranked Momentum Stocks to Buy for July 6th

ZS : 125.49 (-1.51%)
PRPL : 19.73 (+6.82%)
MNTA : 34.30 (+1.99%)
Momenta Pharmace Falls 7.40% on Heavy Volume: Watch For Potential Rebound

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $32.47 to a high of $35.70. Yesterday, the shares fell 7.4%, which took the trading range below the 3-day low of...

MNTA : 34.30 (+1.99%)
The Zacks Analyst Blog Highlights: Domo, ViewRay, Commercial Metals, Clearwater Paper and Momenta Pharmaceuticals

The Zacks Analyst Blog Highlights: Domo, ViewRay, Commercial Metals, Clearwater Paper and Momenta Pharmaceuticals

MNTA : 34.30 (+1.99%)
CLW : 37.08 (+5.70%)
CMC : 19.94 (+4.07%)
VRAY : 2.19 (-0.90%)
DOMO : 35.63 (-6.16%)
Momenta (MNTA) Upgraded to Strong Buy: What Does It Mean for the Stock?

Momenta (MNTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MNTA : 34.30 (+1.99%)
5 Top Momentum Stocks of June Amid Resurgence of Coronavirus

Despite market's roller-coaster ride, a handful of momentum stocks with a favorable Zacks Rank have provided double-digit returns so far in June.

MNTA : 34.30 (+1.99%)
CLW : 37.08 (+5.70%)
CMC : 19.94 (+4.07%)
VRAY : 2.19 (-0.90%)
DOMO : 35.63 (-6.16%)
Look for Shares of Momenta Pharmace to Potentially Pullback after Yesterday's 3.35% Rise

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $35.89 to a high of $39.18. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high...

MNTA : 34.30 (+1.99%)
Momenta Pharmaceuticals, Inc. (MNTA) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Momenta Pharmaceuticals, Inc. (MNTA).

MNTA : 34.30 (+1.99%)
Biotech Stock Roundup: REGN Begins Coronavirus Study, VRTX, BIIB Give Updates

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.

BIIB : 278.88 (+0.06%)
REGN : 620.86 (-3.09%)
MNTA : 34.30 (+1.99%)
GSK : 39.91 (-1.14%)
VRTX : 294.45 (-0.32%)
IDYA : 13.34 (-0.07%)
Momenta (MNTA) Up on Positive Data From Generalized MG Drug

Momenta (MNTA) stock up on the announcement of positive data from a mid-stage study on nipocalimab for the indication of gMG.

ALXN : 108.82 (+0.32%)
REGN : 620.86 (-3.09%)
MYL : 16.10 (+1.39%)
MNTA : 34.30 (+1.99%)
Company News for Jun 16, 2020

Companies in the news are: JKS, MNTA, CAI, CATM

JKS : 21.00 (-4.28%)
MNTA : 34.30 (+1.99%)
CATM : 21.41 (+5.62%)
CAI : 16.38 (+4.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MNTA with:

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 35.51
1st Resistance Point 34.91
Last Price 34.30
1st Support Level 33.45
2nd Support Level 32.60

See More

52-Week High 39.88
Last Price 34.30
Fibonacci 61.8% 28.28
Fibonacci 50% 24.69
Fibonacci 38.2% 21.11
52-Week Low 9.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar